Sports Medicine Associate Sales Representative
About the job
- Bachelor’s degree or equivalent experience
- Travel Requirements: within designated sales territory with 2-4 overnights a month. Infrequent national travel for events and conferences
- All field sales professionals who are required to gain entry into healthcare facilities to perform the basic remit of their role must successfully complete the credentialing process and comply with the requirements of those facilities they support, which can include adherence to any established vaccine protocols.
- Work with a team within an assigned territory and hospital accounts
- Assist in providing clinical case coverage in the operating room
- Secure inventory for those cases
- Observe and consult the surgical team on Smith+Nephew instrumentation and implants
- Complete the logistical requirement associated with those cases
- Collaborate with the Sales Reps within the territory as well as key orthopedic surgeons, hospital and operating room staff, administrators, and clinicians
- Ability to assimilate and learn a high level of technical information as it relates to surgery and procedures
- Minimum two years sales experience in medical device industry preferred
- Preferred experience in the healthcare industry, specifically selling orthopedic products
- Proven track record selling/converting business at the surgeon or hospital level
- Experience leading/mentoring team members and new sales representatives
About the company
Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.
Company Size
10,001+
Company Stage
IPO
Headquarters
Watford, United Kingdom
Founded
1856
Get referred to Smith+Nephew
See people who can refer or advise you
Simplify's Take
What believers are saying
- Q1 2026 revenue reached $1.5 billion, and full-year guidance stayed intact on May 6.
- New launches in 2026 include CORI XT, FLOW FLEXTEND, and ALLEVYN COMPLETE CARE.
- August 2026 H1 results showed 4.6% growth, $200 million efficiency savings, and $500 million buyback.
What critics are saying
- Reuters on August 4, 2026 cut revenue guidance to around 4% after weak U.S. knees.
- Smith+Nephew’s finance chief John Rogers exits September 30, 2026, creating leadership churn.
- A March 2026 humeral nail recall and older hip litigation expose recurring quality risk.
What makes Smith+Nephew unique
- Smith+Nephew’s CORI XT robotics spans knee, shoulder, and future hip workflows.
- Its ASC Solutions bundles facility design, financing, and clinical enablement for outpatient surgery.
- ALLEVYN, RENASYS, and LEAF create a broad wound-care platform with measurable outcomes.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
Dental Insurance
Vision Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Holidays
Flexible Work Hours
Parental Leave
Fertility Treatment Support
Family Planning Benefits
Tuition Reimbursement
Wellness Program
Mental Health Support
Volunteer Time Off
Home Office Stipend
Phone/Internet Stipend
Discounted Stock Options
Health Savings Account/Flexible Spending Account
Employee Assistance Program
PTO/vacation?
Paid Sick Leave
Company News
Smith+Nephew has launched its CARTIHEAL AGILI-C Cartilage Repair Implant in Europe. The product, already introduced in the US during 2024, will be featured at the International Cartilage Regeneration & Joint Preservation Society Summit in Porto, Portugal from 8-10 October. The implant, composed of aragonite (a naturally occurring calcium carbonate), acts as a biphasic scaffold to repair cartilage, restore bone and relieve pain. A recent study published in the American Journal of Sports Medicine showed the implant resulted in higher overall Knee injury and Osteoarthritis Outcome Scores versus surgical standard of care for all time points out to 60 months. The implant will initially launch in twelve countries including Austria, Belgium, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Switzerland and the UK.
Smith & Nephew has issued $700 million in senior notes with a 5.750% coupon maturing in 2036, netting $690.9 million after underwriting fees. The FTSE 100 medical technology firm will primarily use proceeds to fund a tender offer for its existing 2.032% senior notes due 2030, with remaining funds allocated to general corporate purposes. The refinancing replaces lower-yield debt with higher-coupon notes, reflecting current credit market conditions. BofA Securities, J.P. Morgan Securities, Mizuho Securities USA, and SMBC Nikko Securities America managed the transaction, which closed on 11 September 2026. Founded in Hull in 1856, Smith & Nephew operates across orthopaedics, sports medicine, ENT, and advanced wound management. The company employs approximately 17,000 people across 100 countries and reported annual sales of $6.2 billion in 2025.
Corient Private Wealth LP purchased a new stake in Smith & Nephew SNATS, Inc. (NYSE:SNN – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 31,871 shares of the medical equipment provider’s stock, valued at approximately $1,999,000. Other large investors […]
Smith+Nephew has launched the FLOW FLEXTEND COBLATION Wand, a new radiofrequency resection device designed for complex hip procedures. The device features an adjustable-angle tip that provides enhanced joint access and tissue targeting in difficult-to-reach hip, knee, and shoulder anatomies. The wand incorporates Smith+Nephew's FLOW~IQ technology, which automatically balances saline outflow with COBLATION energy. Its design includes a precision electrode with an adjustable tip that improves access to targeted tissues whilst facilitating insertion and removal. The angle adjustment mechanism allows surgeons to set the desired position without continuous manual control. Early surgeon feedback has been positive, with users highlighting improved versatility in the central compartment and precise tissue preservation capabilities compared to existing instruments.
Smith+Nephew has launched ASC Solutions, an enterprise strategy designed to help ambulatory surgery centres optimise costs, improve quality and enhance performance. The initiative provides ASCs with access to clinical expertise, procedural technologies and data analytics to support growth and patient outcomes in value-based care settings. The company is expanding its ASC ONE delivery model into an integrated platform that simplifies centre development and accelerates facility readiness. ASC ONE coordinates services including facility design, construction, financing and clinical enablement through a single point of contact. Smith+Nephew has partnered with STERIS Unity Health Centers, Brasfield & Gorrie, Ghafari and Hopper Healthcare to provide expertise across the ASC lifecycle. The model enables physician-led organisations and health systems to streamline vendor management whilst reducing complexity and improving execution timelines.